Pulmonary Hypertension Due to Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Pulmonary Hypertension Due to Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) [Phase 2]
A Phase 2 clinical trial update for ROC-101 in patients with pulmonary arterial hypertension and pulmonary hypertension due to interstitial …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD [Phase 3]
A Phase 3 clinical trial is evaluating the safety and efficacy of L606 for pulmonary hypertension due to lung disease (PH-ILD) and is curren…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD [Phase 2]
Phase 2 study to evaluate the safety and efficacy of Mirivadelgat in pulmonary hypertension due to interstitial lung disease is currently re…